DIN 02496429 — MAYZENT 0.25 MG
MAYZENT is a tablet of Siponimod marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Siponimod monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02496429
- Brand name
- MAYZENT
- Active ingredient
- Siponimod
- Strength
- 0.25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Sphingosine 1-phosphate (S1P) receptor modulator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Siponimod products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02496437 | MAYZENT | 2 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |